We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

39 hedge funds and large institutions have $7.39M invested in T2 Biosystems, Inc in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

9% less funds holding

Funds holding: 4339 (-4)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

37% less call options, than puts

Call options by funds: $33K | Put options by funds: $52K

42% less capital invested

Capital invested by funds: $12.8M → $7.39M (-$5.38M)

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
16
Reduced
5
Closed
10
Calls
$33K
Puts
$52K
Net Calls
-$19K
Net Calls Change
+$13K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
-$4K -1 Closed
Deutsche Bank
52
Deutsche Bank
Germany
-$3K -1 Closed
BC
53
Barnett & Company
Tennessee
-$2K
EWM
54
Edge Wealth Management
New York
-$1K

TTOO Hedge Fund Activity: Q1 2020 in Review

39 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2020, worth a combined $7.39M — down 42% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TTOO and 9 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 16 added.

The largest buyer was Vanguard Group, adding an estimated $594K. The largest seller was Morgan Stanley, cutting an estimated $1.05M.

  • 39 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2020, down from 43 in Q4 2019.
  • Funds reported $7.39M of T2 Biosystems, Inc stock for Q1 2020, down 42% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q1 2020 and 10 closed out, a net change of -1 holder.
  • The largest T2 Biosystems, Inc buyer in Q1 2020 was Vanguard Group, an estimated $594K added.
  • The largest T2 Biosystems, Inc seller in Q1 2020 was Morgan Stanley, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2020.